Drugs / Vitaliver
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00562783 | Jan 2005 → May 2006 | cirrhosis of liver, hepatitis B virus infection, hepatitis C virus infection | Hospital Authority, Hong Kong | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vitaliver | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00562783 ↗ |